Technology Development & Commercialization

Transforming UHN research innovations into medical products that improve health care outcomes

About us

Commercializing cutting-edge research

Bringing together the innovation, talent and resources needed to fulfil our vision of achieving global health care impact

About us

Bringing UHN technology to market

Creating patient impact and driving research advancement through partnerships and commercialization

About us

UHN Commercialization Fast Facts 2021


Technology Development & Commercialization

Who We Are

We are the team at University Health Network (UHN)—Canada’s largest research hospital—that facilitates the transformation of research innovations into medical products that improve health care. Located in the heart of Toronto’s MaRS Discovery District, the office of Technology Development and Commercialization (TDC) is ideally positioned to collaborate with researchers, clinicians and biotechnology and medical device entrepreneurs in Canada and beyond.

What We Do

We work with scientists and clinicians at UHN to create new intellectual property and advance it towards licensing, research and development partnerships, sponsored research agreements, and new company formation. Our team has extensive experience fostering and identifying technologies with sound commercial potential, managing the intellectual property protection process, and connecting the UHN community with industry and venture partners.

Commercialization at UHN

TDC supports the commercialization of UHN research innovations. As Canada’s largest research hospital, the scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN's four hospitals and seven research institutes employ over 1000 researchers who, along with their staff and students, work across over 1 million square feet of research space and secure annual research funds that exceed $400 million CAD annually. 

Research and commercialization across these research institutes spans the full spectrum of diseases and disciplines, including cancer, cardiovascular sciences, transplantation, neural and sensory sciences, musculoskeletal health, rehabilitation sciences, and community and population health. Learn more about UHN's research areaslife-changing scientific breakthroughs, and Research Institutes.

UHN Inventor of the Year

TDC sponsors this annual award which recognizes UHN researchers that have demonstrated excellence in translating their findings into new technologies, services and products that improve health. Award selection criteria include the degree that the team’s invention has advanced the state-of-the-art, its market suitability, ability to bridge the gap between research and development, and potential impact on quality of life and patient care.
These inventions, along with the many other cutting-edge research innovations made at UHN, demonstrate the world-class creativity and impact that UHN researchers are having on the global health care community.

The Toronto Advantage


TDC supports new company formation by developing business objectives, building management teams, and introducing “start-ups” to funding sources. Some of UHN’s recent featured spin-off companies include Acumyn Inc., DLVR Therapeutics Inc., iDAPT Somno Inc.,, MyndTec Inc., and Northern Biologics Inc.

UHN technology has led to the creation of new companies that are making an impact on health care around the world.  Learn more about some of our start-up companies by clicking on the logos below.

Contact Us

For inquiries about licensing, partnerships and media,
please email
For all other inquiries, please email

Technology Development & Commercialization

University Health Network
101 College Street – Suite 150 – Heritage Building – MaRS Centre
Toronto, Ontario M5G 1L7 Canada
Tel: (416) 581-7408

Find us on map